Blueberries Medical Corp. BBRRF

Company Overview

Blueberries Medical Corp. (OTC: BBRRF) is a cannabis-focused company with operations centered primarily in Colombia. The company has historically operated in the regulated medical cannabis industry, with activities spanning cannabis cultivation, extraction, manufacturing, and distribution for medical and wellness applications. Its business model has focused on leveraging Colombia’s agricultural conditions and comparatively low cultivation costs to produce cannabis-derived products for domestic and export-oriented markets.

The company evolved through the broader expansion of the Latin American cannabis sector following regulatory reforms in Colombia that permitted licensed medical cannabis production and export activity. Public disclosures and market filings indicate that Blueberries Medical pursued vertically integrated operations through licensed cultivation and extraction infrastructure. The company’s positioning has emphasized low-cost production capabilities, access to equatorial growing conditions, and participation in emerging international cannabinoid markets. However, publicly available operational disclosures in recent periods have been limited, and some aspects of current commercial scale and operational status are inconclusive based on available public sources.

Business Operations

Blueberries Medical has historically organized its operations around cannabis cultivation, cannabinoid extraction, and related medical cannabis product development. Its operations included licensed cultivation assets in Colombia intended to support the production of cannabis flower, extracts, and cannabinoid derivatives for pharmaceutical, medical, and wellness applications. Revenue generation was expected to derive from cannabis biomass production, extracts, and downstream product commercialization, although publicly reported revenue levels and commercialization progress have varied across reporting periods.

The company’s operations have primarily been concentrated in Colombia, with strategic emphasis on export potential into international medical cannabis markets. Public filings and investor materials have referenced licensed cultivation and extraction capabilities as core operating assets. Blueberries Medical has also discussed relationships with local Colombian operating entities and regulatory authorities tied to cannabis licensing. Data regarding major active joint ventures, current commercial partnerships, or large-scale international distribution agreements is inconclusive based on available public sources.

Strategic Position & Investments

Blueberries Medical’s strategic direction has centered on participating in the long-term growth of the regulated medical cannabis market, particularly through low-cost cultivation and export-oriented production. The company has historically emphasized Colombia as a strategic operating jurisdiction due to favorable climate conditions, lower labor costs relative to North America, and developing cannabis export regulations. Its strategy has also included vertical integration through cultivation, extraction, and product formulation capabilities.

Public disclosures have referenced investments in cultivation infrastructure, extraction technologies, and regulatory licensing frameworks required for medical cannabis operations. The company has sought exposure to emerging cannabinoid markets and pharmaceutical-grade cannabis supply opportunities. However, detailed information regarding recent acquisitions, material capital investments, or currently active subsidiary expansion initiatives remains limited in publicly available filings. Data concerning the present scale of investment activity and operational growth initiatives is inconclusive based on available public sources.

Geographic Footprint

Blueberries Medical’s operational footprint has primarily been concentrated in Colombia, where the company established cultivation and cannabis-processing activities. The company is headquartered in Canada, reflecting its status as a publicly traded issuer serving North American capital markets while operating agricultural and cannabis assets in Latin America.

The company’s strategic market focus has historically included potential export opportunities into Latin America, North America, and other international medical cannabis jurisdictions where regulations permit cannabinoid imports. Public materials have emphasized Colombia’s role as the company’s primary production base due to favorable climate conditions and cultivation economics. Evidence of large-scale commercial penetration across multiple continents remains limited in public reporting.

Leadership & Governance

Blueberries Medical has operated under a traditional public-company governance structure with executive leadership overseeing cannabis operations, regulatory compliance, and capital markets activities. Public disclosures indicate that leadership strategy has focused on developing scalable medical cannabis production capabilities in Colombia while maintaining access to international public equity markets.

Available public records identify the following executives and leadership figures associated with the company during its public operating history, though some leadership information may have changed and recent updates are limited:

• Facundo Garreton – Founder and former Chairman
• Camilo Villamil – Former Chief Executive Officer
• Diego Izquierdo – Former Chief Financial Officer

More recent executive and board composition data is inconclusive based on available public sources and available regulatory disclosures.